Emcure Pharmaceuticals IPO GMP, Emcure Pharmaceuticals IPO Grey Market Premium Today 2022

Emcure Pharmaceuticals IPO GMP, Emcure Pharmaceuticals Grey Market Premium

Emcure Pharmaceuticals IPO: Emcure Pharmaceuticals IPO GMP (Emcure Pharmaceuticals Grey Market Premium), Emcure Pharmaceuticals IPO Date, Emcure Pharmaceuticals IPO Review, Emcure Pharmaceuticals IPO Benefits & Risks. We will update Emcure Pharmaceuticals GMP daily. Also, all information related to Emcure Pharmaceuticals IPO like price band, all dates, issue size and retail parts etc. All the important information about Emcure Pharmaceuticals IPO is given below.
Emcure Pharmaceuticals IPO GMP

    Emcure Pharmaceuticals IPO

    Emcure Pharmaceuticals primarily develops, manufactures, and markets a wide range of pharmaceutical products globally. The IPO of Emcure Pharmaceuticals Limited is expected in early 2022. Emcure Pharmaceuticals Ltd Has filed its DRHP (Draft Red Herring Prospectus) with market regulator SEBI (Securities and Exchange Board of India) to raise around Rs 1100 crore through IPO (Initial public offering). 

    Emcure Pharmaceuticals IPO will open on January 2022 and close on January 2022. The price band of the Emcure Pharmaceuticals IPO is ₹- to ₹-. The company is looking to raise around ₹1200 crores through an initial public offering (IPO). Emcure Pharmaceuticals IPO QIB quota is 75%, NII quota is 15% and RII quota is 10%. Emcure Pharmaceuticals IPO listing date is - January 2022. Emcure Pharmaceuticals Limited IPO GMP (Grey Market Premium) running well in the grey market.

    Emcure Pharmaceuticals Limited has given excellent financial performance, the company is increasing its profit every year. The company has made a profit of ₹ 418.59 crores in the financial year 2021. Emcure Pharmaceuticals IPO Size is ₹1100 crores. In this IPO, approx 18,168,356 equity shares will be sold under OFS (Offer for sale) and the rest (Approx ₹- Crores) will be sold under fresh issue. The IPO of Emcure Pharmaceuticals will be listed on NSE and BSE.  Emcure Pharmaceuticals IPO face value is ₹- per equity share.

    We will talk about Emcure Pharmaceuticals's financial, benefits, and risks of investing in the company.
    Read About


    What is Emcure Pharmaceuticals IPO GMP Today?
    Emcure Pharmaceuticals IPO GMP is ₹.


    What is the Emcure Pharmaceuticals IPO Date?
    Emcure Pharmaceuticals IPO Opening date is January 2022.


    What is Emcure Pharmaceuticals IPO Expected Return?
    Emcure Pharmaceuticals IPO Expected Returns is approx -%.



    About Emcure Pharmaceuticals Limited

    Since the inception of Emcure Pharmaceuticals, the company has focused on offering a variety of products backed by state-of-the-art R&D and innovative manufacturing solutions. The company is constantly working towards innovating, delivering affordable and high-quality healthcare solutions.

    The company's flagship products are useful in Gynecology, Cardiology, Blood-related, Oncology, Respiratory, CNS, and HIV, etc. The company has launched 6 biosimilars in the domestic market and RoW market, with the company being the domestic leader in three biologics. Not only this, the company is leading the development of the first indigenous mRNA vaccine to be used in the treatment of COVID-19, which is currently under trial.

    Emcure Pharmaceuticals has more than 350 brands, five R&D centers across the country. In addition, the company has 14 manufacturing facilities across the country. The company's presence is not only in India but the company has an extensive network of more than 70 countries. The main objective of the company is to develop, manufacture, and distribute affordable and high-quality health care solutions to the people.

    The company's wide range of products includes oral solids, oral liquids, injections (lipids, liposomal, lyophilized injections), biologics, vaccines, etc.

    The company is now focusing on the neuroscience, antidiabetic, and respiratory therapeutic areas. Company With its strong position in India, several international corporations are engaged in co-marketing and licensing arrangements with them for the sale and distribution of their products in India.

    Important Links:

    Purpose of the offer 

    • To prepay/repay all or a part of the dues raised by the company.
    • To meet general corporate objectives.

    Emcure Pharmaceuticals GMP Today (Grey Market Premium)

    [Note: Emcure Pharmaceuticals Ltd IPO GMP has not started yet]
    DATEGMPKOSTAKSubject to Sauda
    January
    January
    January
    January
    January
    January
    January
    January
    January
    January
    January

    Emcure Pharmaceuticals IPO Date and  Price Band Details

    Emcure Pharmaceuticals IPO open date: January 2022, Closing date: January 2022, and Listing date: January 2022. The price band of Emcure Pharmaceuticals IPO is ₹- to ₹-per share. Emcure Pharmaceuticals IPO issue size is Rs 1100 crores. Emcure Pharmaceuticals Ipo retails portion is 10%, QIB Portion is 75%, and NII Portion is 15%.

    IPO Open:January 2022
    IPO Close:January 2022
    Listing Date:January 2022
    Listing On:NSE & BSE
    IPO Size:Approx ₹1100Crores
    Fresh Issue:Approx ₹-Crores
    Offer For Sale:Approx 18,168,356 Eq shares
    Price Band:₹- to ₹- per share
    Face Value:₹10 per Equity share
    QIB Portion:50%
    Retail Portion:35%
    NII Portion:15%
    Employee Res:Not Disclosed

    Emcure Pharmaceuticals IPO Market Lot & Size

    Emcure Pharmaceuticals IPO's minimum lot size is - shares with ₹- application amount and the maximum lot size are - shares with ₹- application amount.

    Minimum Lot:01
    Minimum Lot Size:- Shares
    Minimum Amount:₹-
    Maximum Lot:13
    Maximum Lot Size:- Shares
    Maximum Amount:₹-

    Emcure Pharmaceuticals IPO Allotment & Listing Date

    Ipo Opening Date:January 2022
    IPO Closing Date:January 2022
    Basis of Allotment:January 2022
    Refund Date:January 2022
    Credit to Demat Account:January 2022
    Listing Date:January 2022

    Emcure Pharmaceuticals IPO Review

    HappiestPost View: To be updated.

    Brokerage Firm IPO Reviews

    • Motilal Oswal: To be updated
    • ICICI Securities: To be updated
    • Capital Market: To be updated
    • Ventura Securities Limited: To be updated
    • GEPL Capital Ltd: To be updated soon

    Emcure Pharmaceuticals Ipo Review

    [Not rated yet (To be updated)]

    Review For Listing Gain


    Review For Short term


    Review For Long term


    Strength

    • The company has an experienced Board of Directors and a highly qualified management team.
    • The company has made excellent financial performance. The company has made a profit of ₹ 418 crores in the financial year 2021.
    • The company is continuously working towards providing affordable and high-quality healthcare solutions.
    • The company is the domestic leader in the three biologics.
    • The company has more than 350 brands, five R&D centers across the country.
    • The company has 14 manufacturing facilities across the country.
    • The company has a presence not only in India but also in more than 70 countries.
    • The main objective of the company is to develop, manufacture and deliver affordable and high-quality health care solutions to the people.

    Risks

    • The company depends on other companies for some raw materials, temporarily the company may suffer due to raw material constraints.
    • The impact of the COVID-19 pandemic on the company's business and operations is still unknown.
    • The promoters of the company and their directors are subject to legal proceedings. Negative results in a legal battle can have a bad effect on their company.
    • Interruptions in production or research by the company can have a negative impact on the company's business.
    • A company's business may suffer if for any reason infringes the patents of others.
     

    Emcure Pharmaceuticals Financials

    Emcure Pharmaceuticals Financials(in Crores)

    YearTotal AssetsRevenueProfit
    2019₹5810₹4815₹202
    2020₹60045130₹100
    2021₹6807₹6091₹418


    Promoters

    The promoters of the company are:
    • Satish Mehta
    • Sunil Mehta

    Contact Details of Emcure Pharmaceuticals

    Emcure Pharmaceuticals Limited
    Emcure House, T-184, M.I.D.C., Bhosari,
    Pune – 411 026, Maharashtra, India.
    Tel: +(91) 20 35010000/ 40700000

    Emcure Pharmaceuticals Lead Managers

    • Axis Capital Limited
    • JM Financial Limited
    • BofA Securities India Limited
    • BOB Capital Markets Limited
    • Credit Suisse Securities (India) Private Limited

    Emcure Pharmaceuticals IPO Registrars

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    L.B.S. Marg, Vikhroli West,
    Mumbai 400 083
    Maharashtra, India
    Tel: +91 22 4918 6200
    E-mail: emcurepharma.ipo@linkintime.co.in

    Conclusion

    Emcure Pharmaceuticals primarily develops, manufactures, and manufactures a wide range of Pharmaceuticals across the globe. Considering the financial position of the Company, the Company has an excellent financial track record. The company has made a profit of ₹418 crores in the financial year 2021. Our suggestion will be updated when the Emcure Pharmaceuticals IPO price band and other IPO details are announced. Emcure Pharmaceuticals Limited's financial statement and other information is given above.


    Emcure Pharmaceuticals IPO FAQs

    What is Emcure Pharmaceuticals IPO GMP Today?
    Emcure Pharmaceuticals IPO GMP is ₹- as of today.

    What is Emcure Pharmaceuticals IPO Opening Date?
    Emcure Pharmaceuticals IPO Opening date is January 2022.

    What is the Emcure Pharmaceuticals IPO Closing Date?
    Emcure Pharmaceuticals IPO Closing date is January 2022.

    What is the Emcure Pharmaceuticals IPO Allotment date?
    Emcure Pharmaceuticals IPO Allotment Date is January 2022.

    What is Emcure Pharmaceuticals IPO Listing Date?
    Emcure Pharmaceuticals IPO Date is January 2022.

    What is Emcure Pharmaceuticals IPO Kostak Rate?
    Emcure Pharmaceuticals IPO Kostak rate is ₹-.

    What is Emcure Pharmaceuticals IPO Expected Returns?
    Emcure Pharmaceuticals IPO Expected Returns is -%.


    Read More:
    👉🏻 Waare Energies IPO GMP and Details.

    For other important information related to the stock market and Grey Market Premium, Costak rate, you can click on the links given below. Know about Upcoming IPO.

    How to Apply the Emcure Pharmaceuticals Ltd IPO with Zerodha?

    1. Open your Zerodha kite app and visit the Account tab, then see for console and click on IPO. 
    2. If you are a Desktop user then Log in to Console on Zerodha Website. Go to Portfolio and Click on IPO. 
    3. You will see the IPO name "Emcure Pharmaceuticals Ltd". 
    4. Then, Click on Bid Button.
    5. Then, Enter your UPI ID.
    6. Then, Fill in Quantity and Price. (we recommend, you should choose the cutoff price.) 
    7. Then Submit the IPO Application Form. 
    8. Now go to your UPI App (PhonePe, Google Pay, etc)  or BHIM App to Approve the mandate.


    Disclaimer

    1. We are not involved in gray market trading in any way. And do not provide the facility to buy or sell any IPO from IPO. 
    2. Reference to IPO Grey Market Premium (IPO GMP) is valid only for the date specified in the header. 
    3. We are not involved in the buying or selling of IPO form. 
    4. Do not decide to subscribe to an IPO solely based on GMP (Grey Market Premium), as this can change at any time. Research the fundamentals and financial statements of companies before subscribing.

    We hope you like this article about Emcure Pharmaceuticals IPO. If you have a query about Emcure Pharmaceuticals IPO Please post a comment. 

    Thanks For Visiting & Happy Investing.


    Happiest Post.


    Post a Comment

    0 Comments